Product Description
Vudalimab Antibody, Monoclonal | 21-990 | ProSci
Product Type: Primary Antibodies
Category: Primary Antibodies, Monoclonal Antibodies
Research Area: Drug Analogues
Type: Monoclonal
Host Species: N/A
Reactivity Species: N/A
Homology: N/A
Immunology: Humanized / CTLA4, PDCD1
Tested Application: N/A
Application Note: N/A
Positive Control 1: N/A
Positive Control 2: N/A
Predicted Molecular Weight: N/A
Isoform: N/A
Purification: >95%
Clonality: Recombinant Monoclonal
Clone: N/A
Isotype: Bispecific, IgG1, Kappa;Kappa
Conjugate: Unconjugated
Physical State: N/A
Buffer: PBS buffer pH 7.5
Concentration: N/A
Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks) . Store at -20 °C 12 months. Store at -80°C long term.
Additional Names: ANTI-PD-1/ANTI-CTLA-4 XMAB20717, ANTI-PD1/CTLA4 BISPECIFIC ANTIBODY XMAB20717, IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI- (HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152) ) AND ANTI- (HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279) ), MONOCLONAL ANTIBODY, BISPECIFIC PD-1 X CTLA-4 DUAL CHECKPOINT INHIBITOR XMAB20717 VUDALIMAB, VUDALIMAB [INN], XMAB20717, XMAB-20717, CD; GSE; GRD4; ALPS5; CD152; CTLA-4; IDDM12; CELIAC3
Protein Accession: P16410
User Note: For research use only .
Background:
Loading Controls: N/A
Source: CHO cells
Purity: >95%
CAS: 2329669-72-7
Shipping Condition: N/A